| 產品編號 | bs-47026P |
| 英文名稱 | Recombinant human CD86 / B7-2 protein, C-His-Avi (HEK293) |
| 中文名稱 | 重組人CD86/B7-2蛋白 |
| 別 名 | CD28LG2; FUN1; LAB72; Activation B7 2 antigen; Activation B7-2 antigen 3; CD86_HUMAN; Activation B7-2 antigen; Activation B72 antigen; B lymphocyte activation antigen B7 2; B lymphocyte activation antigen B72; B-lymphocyte activation antigen B7-2 2; B-lymphocyte activation antigen B7-2; B7 2; B7 2 antigen; B7; B7-2; B7.2; B70; B72 antigen; BU63; CD 86; CD28 antigen ligand 2 2; CD28 antigen ligand 2; Cd28l2; CD28LG2; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) 1, 2; CD86 antigen; CD86 molecule; CLS1; CTLA 4 counter receptor B7 2; CTLA 4 counter receptor B7.2; CTLA-4 counter-receptor B7.2 2, 3; CTLA4 counter receptor B72; Early T-cell costimulatory molecule 1; ETC-1; FUN 1; LAB72; Ly-58; Ly58; MB7; MB7-2; Membrane glycoprotein; MGC34413; T lymphocyte activation antigen CD86; T-lymphocyte activation antigen CD86; TS/A-2; Recombinant human CD86 / B7-2 protein, C-His-Avi (HEK293) |
| 理論分子量 | 28.2kDa |
| 檢測分子量 | Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result. |
| 性 狀 | Lyophilized powder |
| 濃 度 | ＞0.5 mg/ml |
| 物 種 | Human |
| 序 列 | 26-247/329 |
| 純 度 | >95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC |
| 純化方法 | AC |
| 內毒素 | <1.0 EU/μg as determined by LAL |
| 表達系統 | HEK293 cell |
| 活性 | Not tested |
| 標簽 | C-His-Avi |
| 緩 沖 液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4) with 5 mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 | |
| 產品圖片 |  Human CD86/B7-2 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.  The purity of Human CD86/B7-2 is greater than 95% as determined by SEC-HPLC. |
我要詢價
*聯系方式：
(可以是QQ、MSN、電子郵箱、電話等，您的聯系方式不會被公開)
*內容：
